Mirai Bio
Mirai Bio is enabling genetic medicines from promise to performance by solving delivery challenges that have limited the field. Mirai’s platform combines proprietary in vivo biodistribution data, machine learning-guided LNP optimization, modular targeted particle design, and translation and manufacturing expertise. Mirai’s precise, scalable delivery of diverse nucleic acid payloads to specific cells and tissues beyond the liver, helps partners move faster, reduce technical risk, and pursue highvalue programs making delivery a strategic advantage.
